Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January ...

Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.

Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...

Amgen says its MariTide obesity drug helped patients maintain weight loss for a second year, with good safety and fewer side effects.

Bank of America Securities analyst Tazeen Ahmad maintained a Sell rating on Amgen today and set a price target of $304.00. Ahmad covers the Healthcare sector, focusing on stocks such as Neurocrine, ...

Amgen (NASDAQ: AMGN) has outperformed the market over the past 15 years by 1.17% on an annualized basis producing an average annual return of 13.01%. Currently, Amgen has a market capitalization of ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

Amgen (AMGN) stock update: analysts upgrade to Buy on MariTide obesity drug, pipeline and 2.9% dividend, despite mixed ...

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the ...

Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...

Both Novo Nordisk NVO and Amgen AMGN are large-cap, innovation-driven healthcare leaders with global scale, strong balance sheets, and a track record of turning scientific breakthroughs into ...

For this list, we screened for S&P 500 companies with a market cap of at least $10 billion and identified stable dividend ...